Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$29.53

0.02 (0.07%)

05:50
02/27/18
02/27
05:50
02/27/18
05:50

Exelixis upgraded to Outperform with $40 target at Oppenheimer

Oppenheimer analyst Leah Rush Cann upgraded Exelixis to Outperform from Perform with a $40 price target. The analyst is now applying a valuation methodology for profitable companies to Exelixis, since the company turned profitable for the full-year 2017. She expects Exelixis will continue to develop its commercial drugs, Cabometyx and Cometriq, while its partner Genentech will continue to develop Cotellic. Cann views the company's Q4 results as "strong."

  • 27

    Feb

EXEL Exelixis
$29.53

0.02 (0.07%)

10/16/17
PIPR
10/16/17
NO CHANGE
Target $33
PIPR
Overweight
Exelixis price target raised to $33 from $29 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Exelixis shares to $33 after the company said the Phase III Celestial trial of Cabometyx met the primary endpoint. The analyst is confident front-line approval next year will grow renal cell carcinoma product sales to $392M in 2018. He reiterates an Overweight rating on Exelixis.
10/17/17
NEED
10/17/17
NO CHANGE
Target $33
NEED
Buy
Exelixis price target raised to $33 from $30 at Needham
Needham analyst Chad Messer raised his price target on Exelixis (EXEL) to $33, noting the latest trial data for advanced renal cell carcinoma treatment, Cabozantinib, positions it for near and long term growth. Messer says the results may be sufficient to allay competitive concerns from the recently approved Bayer (BAYRY) Stivarga, as cabozantinib offers a potentially more attractive efficacy profile.
01/04/18
PIPR
01/04/18
NO CHANGE
Target $37
PIPR
Overweight
Piper ups Exelixis target to $37, names a top pick for 2018
Piper Jaffray analyst Edward Tenthoff names Exelixis a top pick for 2018 and raised his price target for the shares to $37 from $33. The analyst expects Cabometyx growth from driven label expansion and is positive into the Phase III Cotexo data in the first half of 2018.
02/27/18
OPCO
02/27/18
UPGRADE
OPCO
Outperform
Exelixis upgraded to Outperform from Perform at Oppenheimer

TODAY'S FREE FLY STORIES

LYB

LyondellBasell

$102.16

-1.3 (-1.26%)

05:01
09/19/18
09/19
05:01
09/19/18
05:01
Downgrade
LyondellBasell rating change  »

LyondellBasell downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSEZY

SSE

$0.00

(0.00%)

04:57
09/19/18
09/19
04:57
09/19/18
04:57
Upgrade
SSE rating change  »

SSE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLK

Allakos

$44.88

0.95 (2.16%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
RBC Capital hardware analyst to hold a group luncheon »

Hardware & Semis…

WCN

Waste Connections

$80.19

0.745 (0.94%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Waste Connections participates in a conference call with UBS »

Analyst Windham holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 EIA…

HHC

Howard Hughes

$124.65

-0.88 (-0.70%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Howard Hughes management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BAESY

BAE Systems

$0.00

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
BAE Systems management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Housing Starts to be reported at 08:30 »

August Housing Starts…

AMSF

Amerisafe

$63.80

-0.35 (-0.55%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Amerisafe management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AKTS

Akoustis

$8.08

0.04 (0.50%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Akoustis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

ATTO

Atento

$7.60

-0.1 (-1.30%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Atento management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GCI

Gannett

$9.92

0.135 (1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Gannett management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NHI

National Health Investors

$76.47

-1.07 (-1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
National Health Investors management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

RWT

Redwood Trust

$16.42

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Redwood Trust management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NEE

NextEra Energy

$173.44

-0.41 (-0.24%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
NextEra Energy management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 11

    Nov

NICE

Nice Systems

$115.64

-0.61 (-0.52%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 MBA Mortgage…

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Housing Starts Permits to be reported at 08:30 »

August Housing Starts…

ESE

Esco Technologies

$67.00

-0.1 (-0.15%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Esco Technologies management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 06

    Nov

GNBC

Green Bancorp

$23.10

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Green Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

NP

Neenah Paper

$94.65

-1.35 (-1.41%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Neenah Paper management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

VCTR

Victory Capital

$9.23

-0.25 (-2.64%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Victory Capital management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

VSM

Versum Materials

$35.65

-0.305 (-0.85%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Versum Materials management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CHKP

Check Point

$119.67

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Check Point management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Dec

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.